StockWatch
·
HomeLiveReports

Ernexa Therapeutics Inc.

Ticker: 748592

OverviewP/LShare Hold
values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-31.46-17.41-3.3610.69Q3 FY23Q1 FY24Q1 FY24Q2 FY24Q2 FY24Q3 FY24Q3 FY24

Margin Trend

percentage
OPM %NPM %
-102.00-100.67-99.33-98.00Q3 FY23Q1 FY24Q1 FY24Q2 FY24Q2 FY24Q3 FY24Q3 FY24
PeriodQ3 FY24Q3 FY24Q2 FY24Q2 FY24Q1 FY24Q1 FY24Q3 FY23
INCOME
Revenue0.49+0.0%0.49+880.0%0.05+0.0%0.05+0.0%0.05+0.0%0.05+0.0%0.05
Total Income0.49+0.0%0.49+880.0%0.05+0.0%0.05+0.0%0.05+0.0%0.05+0.0%0.05
EXPENSES
Expenditure2.75+0.0%2.75-44.8%4.98+0.0%4.98-14.6%5.83+0.0%5.83+4.9%5.56
Tax0.01+0.0%0.010.000.000.000.00+100.0%-0.01
PROFIT
PBT-26.59+0.0%-26.59-380.8%-5.53+0.0%-5.53+16.7%-6.64+0.0%-6.64-18.6%-5.60
Net Profit-26.60+0.0%-26.60-381.0%-5.53+0.0%-5.53+16.8%-6.65+0.0%-6.65-19.0%-5.59
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-4.92+93.3%-73.70-7125.5%-1.02+93.4%-15.34-1147.2%-1.23+0.0%-1.23-19.4%-1.03

Corporate Events

Board MeetingERNA
2027
1Jul

Board Meeting

Annual Meeting of Stockholders to elect directors, ratify th…

SEC Filing ↗
Board MeetingERNA
2026
14Sep

Board Meeting

Robert J. Spiegel, M.D. appointed to the Board of Directors.…

SEC Filing ↗
Board MeetingERNA
2026
3Jul

Board Meeting

Sandra Gurrola resigned as Senior Vice President of Finance,…

SEC Filing ↗
Stock SplitERNA
2026
4May

1:25

SEC Filing ↗